Pharmaceuticals
10 Eli Lilly legal leaders
These ten current and former Eli Lilly legal leaders have held assistant general counsel, associate vice president and regional legal director roles at Lilly, covering regulatory, litigation, securities, market access, consumer operations, therapeutic areas and European legal teams. A reader can learn how legal leaders work at Eli Lilly from people who have held the role.
Professionals to explore
01—10Amy Jay
LinkedInExperience: Associate Vice President, Assistant General Counsel - Cardiometabolic Health Legal · Eli Lilly and Company
Associate Vice President, Assistant General Counsel - Cardiometabolic Health Legal at Eli Lilly and Company since June 2024, after holding the same title for Oncology Legal (2022–2024). Amy Jay also served as Legal Counsel - Oncology Legal (2019–2022) and Counsel - Managed Healthcare Services (2016–2019) at Lilly, and earlier as Counsel, Commercial and Compliance at GE.
Camilla Cocuzza
LinkedInExperience: Associate Vice President General Counsel Italy Hub · Eli Lilly and Company
Associate Vice President General Counsel Italy Hub at Eli Lilly and Company since December 2025; a highlight says the role covers Italy and the Czech, Israel, Poland and Romania clusters. At Lilly Camilla Cocuzza was also Sr. Director Legal Counsel Italy and IBU (2024–2025), Sr. Director - Counsel, Lilly Diabetes and Obesity (2022–2024) and Associate Director - Legal Counsel, Italy Hub (2020–2022).
Catherine Clements
LinkedInExperience: Associate VP and Assistant General Counsel—Regulatory Legal · Eli Lilly and Company
Associate VP and Assistant General Counsel, Regulatory Legal at Eli Lilly and Company since March 2022. At Lilly Catherine Clements was also Assistant General Counsel, Regulatory Legal (2019–2022) and Counsel, Regulatory Legal (2016–2022), and earlier worked there as a Medical Writer (2003–2006) and as an attorney at Express Scripts Pharmacy Benefit Services.
John Rudolph
LinkedInExperience: Associate Vice President and Assistant General Counsel · Eli Lilly and Company
Associate Vice President and Assistant General Counsel at Eli Lilly and Company since March 2022, after serving as Assistant General Counsel there (2008–2022). A highlight lists expertise in pharmaceutical advertising and marketing, trademarks, copyrights, collaboration contracting and licensing. John Rudolph is also an adjunct professor at Indiana University Robert H. McKinney School of Law.
Jonathan Groff
LinkedInExperience: Associate VP - Assistant General Counsel - Corporate Securities and Assistant Secretary · Eli Lilly and Company
Associate VP - Assistant General Counsel - Corporate Securities and Assistant Secretary at Eli Lilly and Company since October 2024. At Lilly Jonathan Groff was also Executive Director - Counsel - Corporate Securities (2023–2024) and Senior Director - Corporate Securities (2021–2023), and earlier was Of Counsel at Ice Miller LLP and a staff attorney in the SEC Division of Corporation Finance.
Kevin Yamaga-Karns
LinkedInExperience: Former Sr. Director/Assistant General Counsel, US Biomedicines · Eli Lilly and Company
Former Sr. Director/Assistant General Counsel, US Biomedicines at Eli Lilly and Company (2014–2018). Kevin Yamaga-Karns also held Sr Director, Japan Legal & Compliance at Eli Lilly and Company (2002–2011) and Senior Director, General Counsel at Eli Lilly Japan, K.K. (2018–2022), and has been Associate VP, General Counsel at Eli Lilly Japan K.K. since October 2022.
Megan Fitzpatrick
LinkedInExperience: Associate Vice President, Assistant General Counsel - Litigation · Eli Lilly and Company
Associate Vice President, Assistant General Counsel - Litigation at Eli Lilly and Company since October 2022, tagged at vice president level in legal and based in the Chicago area. Megan Fitzpatrick previously was an attorney at Latham & Watkins (2012–2022) and earlier a summer intern at LAF (2010).
Mike Dreyfuss
LinkedInExperience: Associate Vice President - Assistant General Counsel - Lilly Value and Access Legal · Eli Lilly and Company
Associate Vice President - Assistant General Counsel - Lilly Value and Access Legal at Eli Lilly and Company since September 2019; a highlight says Mike Dreyfuss advises Lilly Value & Access on interactions with PBMs, payers, pharmacies and channel accounts. The profile also lists attorney roles at Latham & Watkins (2014–2019) and Waller (2012–2014).
Sonia Arnold
LinkedInExperience: Associate Vice-President, Assistant General Counsel- Consumer/Customer Operations · Eli Lilly and Company
Associate Vice-President, Assistant General Counsel - Consumer/Customer Operations at Eli Lilly and Company since April 2022. At Lilly Sonia Arnold has also been Sr. Director, Assistant General Counsel - Consumer/Customer Operations (2020–2022), General Counsel - Lilly Oncology (2018–2020) and Assistant General Counsel for Lilly Diabetes and for litigation and legal compliance.
Tomasz Kubicki
LinkedInExperience: Legal Director, Northern Europe (UK & Nordics) & General Counsel Nordics · Eli Lilly and Company
Legal Director, Northern Europe (UK & Nordics) & General Counsel Nordics at Eli Lilly and Company since February 2026, tagged at director level. At Lilly Tomasz Kubicki was also General Counsel CEE (2023–2026) and Legal Director Central European Cluster (2021–2023), and earlier was a Senior Associate at Domanski Zakrzewski Palinka (DZP).
Choose the right perspective
Pick the person whose Lilly legal team matches your question, such as regulatory law, litigation, securities and corporate governance, pricing and market access, a therapeutic area, or legal work in European markets. Check each person's dates to see whether their Lilly experience is current or from an earlier period.
Questions to take into the conversation
- 01How do you organize legal support around therapeutic areas at a large pharmaceutical company?
- 02What does a regulatory legal team handle that a product litigation team does not?
- 03How do regional legal directors in Europe work with the central legal team in the United States?
Reaching Eli Lilly legal leaders
How can I contact one of these Eli Lilly legal leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Eli Lilly and Company, based on profile data retrieved on October 15, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Eli Lilly legal leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Eli Lilly legal leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal